Dr Mansur A Khan, MD | |
9305 W Thomas Rd, Suite 355, Phoenix, AZ 85037-3328 | |
(623) 907-8686 | |
(623) 907-8440 |
Full Name | Dr Mansur A Khan |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 43 Years |
Location | 9305 W Thomas Rd, Phoenix, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770532020 | NPI | - | NPPES |
024635 | Medicaid | AZ | |
2Z7084 | Other | AZ | HEALTH NET |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 34541 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mt Graham Regional Medical Center Inc | 6204822364 | 26 |
News Archive
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.
Dr. Siegal & Son, LLC, a new Vienna, Virginia based company launched by renowned physician and author Sanford Siegal, D.O., M.D., and his son, Matthew Siegal, the duo behind the internationally popular Dr. Siegal's COOKIE DIET brand, has introduced CalciOs cookies, a snack food that's enriched with calcium carbonate, a common source of dietary calcium supplementation that also neutralizes stomach acid and relieves occasional heartburn. U.S. and international patents are pending.
The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
› Verified 1 days ago
Entity Name | Yuma Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.
Dr. Siegal & Son, LLC, a new Vienna, Virginia based company launched by renowned physician and author Sanford Siegal, D.O., M.D., and his son, Matthew Siegal, the duo behind the internationally popular Dr. Siegal's COOKIE DIET brand, has introduced CalciOs cookies, a snack food that's enriched with calcium carbonate, a common source of dietary calcium supplementation that also neutralizes stomach acid and relieves occasional heartburn. U.S. and international patents are pending.
The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
› Verified 1 days ago
Entity Name | Mt Graham Regional Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275588345 PECOS PAC ID: 6204822364 Enrollment ID: O20040423000105 |
News Archive
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.
Dr. Siegal & Son, LLC, a new Vienna, Virginia based company launched by renowned physician and author Sanford Siegal, D.O., M.D., and his son, Matthew Siegal, the duo behind the internationally popular Dr. Siegal's COOKIE DIET brand, has introduced CalciOs cookies, a snack food that's enriched with calcium carbonate, a common source of dietary calcium supplementation that also neutralizes stomach acid and relieves occasional heartburn. U.S. and international patents are pending.
The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
› Verified 1 days ago
Entity Name | Banner Physician Specialists Arizona Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316228802 PECOS PAC ID: 6204002272 Enrollment ID: O20111222000509 |
News Archive
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.
Dr. Siegal & Son, LLC, a new Vienna, Virginia based company launched by renowned physician and author Sanford Siegal, D.O., M.D., and his son, Matthew Siegal, the duo behind the internationally popular Dr. Siegal's COOKIE DIET brand, has introduced CalciOs cookies, a snack food that's enriched with calcium carbonate, a common source of dietary calcium supplementation that also neutralizes stomach acid and relieves occasional heartburn. U.S. and international patents are pending.
The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
› Verified 1 days ago
Entity Name | Arizona Centers For Digestive Health Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568975316 PECOS PAC ID: 5193083087 Enrollment ID: O20171226000651 |
News Archive
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.
Dr. Siegal & Son, LLC, a new Vienna, Virginia based company launched by renowned physician and author Sanford Siegal, D.O., M.D., and his son, Matthew Siegal, the duo behind the internationally popular Dr. Siegal's COOKIE DIET brand, has introduced CalciOs cookies, a snack food that's enriched with calcium carbonate, a common source of dietary calcium supplementation that also neutralizes stomach acid and relieves occasional heartburn. U.S. and international patents are pending.
The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
› Verified 1 days ago
Entity Name | Mt Graham Regional Medical Center Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1275588345 PECOS PAC ID: 6204822364 Enrollment ID: O20201016000847 |
News Archive
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.
Dr. Siegal & Son, LLC, a new Vienna, Virginia based company launched by renowned physician and author Sanford Siegal, D.O., M.D., and his son, Matthew Siegal, the duo behind the internationally popular Dr. Siegal's COOKIE DIET brand, has introduced CalciOs cookies, a snack food that's enriched with calcium carbonate, a common source of dietary calcium supplementation that also neutralizes stomach acid and relieves occasional heartburn. U.S. and international patents are pending.
The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mansur A Khan, MD Po Box 1040, Tolleson, AZ 85353-1040 Ph: (623) 907-8686 | Dr Mansur A Khan, MD 9305 W Thomas Rd, Suite 355, Phoenix, AZ 85037-3328 Ph: (623) 907-8686 |
News Archive
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
The Canadian Centre on Substance Abuse (CCSA) today announced that it will open Issues of Substance (IOS) 2009, Canada's biennial conference on substance abuse, with a focus on the role of treatment systems. More than 13 sessions will examine the role of treatment from a variety of perspectives, including the Models of Care project in the UK, the National Treatment Strategy in Canada (NTS) and case study and research presentations reviewing the effectiveness of a variety of integrated programs in Canada.
Dr. Siegal & Son, LLC, a new Vienna, Virginia based company launched by renowned physician and author Sanford Siegal, D.O., M.D., and his son, Matthew Siegal, the duo behind the internationally popular Dr. Siegal's COOKIE DIET brand, has introduced CalciOs cookies, a snack food that's enriched with calcium carbonate, a common source of dietary calcium supplementation that also neutralizes stomach acid and relieves occasional heartburn. U.S. and international patents are pending.
The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
› Verified 1 days ago
Moustafa I Hazin, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165 | |
Dr. Ali Shaheen Al-yaqoobi, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411 | |
Dana Archbold, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084 | |
Catalina Nicole Flores, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000 | |
Kristina Yancey, Gastroenterology Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000 | |
Dr. Francisco Cordova, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971 | |
Dr. Dimpy Kapoor, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013 |